Study Stopped
No funding obtained.
Trial of Computerized MET for Adolescent Substance Use
Randomized Controlled Trial of Computerized MET for Adolescent Substance Use
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to test the effects of a computerized, self-directed Motivational Enhancement Therapy program for adolescent substance use (iMET), in comparison to clinician-delivered MET and Treatment As Usual (TAU), on treatment engagement and substance use. The investigators hypothesize that both iMET and MET will be more effective than TAU in engaging/retaining patients in treatment and in reducing substance use during a 12-month follow-up period. The investigators also hypothesize that Self-directed iMET will be as effective as the clinician-guided MET in increasing treatment engagement and abstinence during the 12-months follow-up period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2013
CompletedFirst Posted
Study publicly available on registry
February 6, 2013
CompletedStudy Start
First participant enrolled
October 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedApril 12, 2017
April 1, 2017
3.3 years
February 4, 2013
April 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment engagement
We will compare the number of individual visits in the program, the number of group sessions completed, and the number of urine screens completed during a 12 month follow-up period by each participant in the three study arms.
12 months
Secondary Outcomes (3)
Days abstinent
past-90-days
Driving/Riding Risk
past-90-days
HIV Risk Behavior
past-90-days
Other Outcomes (1)
Treatment process/quality
60 days
Study Arms (3)
Treatment as Usual
NO INTERVENTIONPatients will receive the usual care from the treatment program
iMET
EXPERIMENTALParticipants will complete a self-guided computerized Motivational Enhancement Therapy
MET
EXPERIMENTALClinician-delivered Motivational Enhancement Therapy
Interventions
Eligibility Criteria
You may qualify if:
- completed initial visit at the treatment program;
- be available to return for iMET/MET sessions (if assigned)
- be available to complete all follow-up measurements
- a past-12-month CRAFFT score \>1
- have used substances on \>6 days (not including tobacco use) during the 90 days preceding their visit
You may not qualify if:
- unable to speak and understand English, or read English at a 5th grade reading level
- youth deemed by the clinical team to require immediate hospitalization or referral to more intensive residential treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sion K Harris, PhD
Boston Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-Director, Center for Adolescent Substance Abuse Research
Study Record Dates
First Submitted
February 4, 2013
First Posted
February 6, 2013
Study Start
October 1, 2013
Primary Completion
January 1, 2017
Last Updated
April 12, 2017
Record last verified: 2017-04